Prenetics' IM8 Brand Surges with $16.7M Monthly Revenue, Raising Full-Year Guidance
Event summary
- IM8 revenue reached $16.7M in May 2026, implying $200M in annualized recurring revenue.
- Prenetics raised full-year 2026 IM8 revenue guidance to $190M–$210M from $180M–$200M.
- Q1 2026 IM8 revenue grew 23.1% sequentially and nearly 6x year-over-year.
- Prenetics divested digital asset holdings for $41.3M in May 2026.
- Three new SKUs planned for Q4 2026 in Hydration, Creatine, and Kids’ Gummies categories.
The big picture
Prenetics' IM8 brand is demonstrating strong global traction, with significant revenue growth and strategic product expansions. The company's ability to maintain gross margin improvements and scale internationally will be critical as it competes in the crowded consumer health market. The strategic partnerships with high-profile athletes and sports teams further bolster IM8’s brand positioning, but execution on new product launches will be key to sustaining momentum.
What we're watching
- Revenue Growth
- Whether IM8 can sustain its 33% sequential quarterly growth into Q2 2026.
- Product Expansion
- The impact of new SKUs in Hydration, Creatine, and Kids’ Gummies on IM8’s market share.
- Global Scaling
- How IM8’s expansion into 43 countries will affect its operational efficiency and customer acquisition costs.
Related topics